Concord Medical - Spon ADRCCM
13F holders, Q3 2024 (September 30)2holders
$7.01avg. 13F price*
At the end of Q3 2024, 2 institutions reported holding Concord Medical - Spon ADR (CCM) in their 13F filings. The largest holders were Rhumbline Advisers ($17K) and UBS Group AG ($6K).
- Company
- Concord Medical - Spon ADR
- CUSIP
- 206277204
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $24K |
| Exits | 0 | $0 |
Ownership 2 holders
| Rhumbline Advisers | 0.00% | New | 2,460 | $17K |
| UBS Group AG | 0.00% | New | 923 | $6K |
"% of holder's portfolio" is CCM's weight in each manager's 13F, not the share of Concord Medical - Spon ADR the manager owns.